Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Organon & (OGN)

Organon Q2 revenue falls 1% to $1.594 billion; full-year revenue guidance raised

Mixed Impact 4 of 5 earnings Written later

Organon reported second-quarter 2025 revenue of $1.594 billion, down 1% from a year earlier, and GAAP diluted earnings per share of $0.56 versus $0.75. The company raised its full-year 2025 revenue guidance to $6.275 billion to $6.375 billion, while affirming its Adjusted EBITDA margin range of 31.0% to 32.0%.

Key points

  • Q2 2025 revenue was $1.594 billion versus $1.607 billion in Q2 2024; net income was $145 million versus $195 million.
  • Non-GAAP Adjusted diluted EPS was $1.00 versus $1.12; GAAP diluted EPS of $0.56 includes a $46 million gain on early debt extinguishment.
  • Full-year 2025 revenue guidance rose to $6.275 billion to $6.375 billion from $6.125 billion to $6.325 billion, based on current foreign exchange views.
  • The company repaid $345 million of long-term debt in the quarter and is on track for a net debt to Adjusted EBITDA ratio below 4.0x by year-end.

The filing

CompanyOrganon & (OGN)
Form8-K, current report
Filed with the SECAug 5, 2025, 7:44 AM ET
Accession number0001104659-25-073929

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.